What are implications after regulators’ AstraZeneca jab findings?
The European Medicines Agency says the link between AstraZeneca vaccine and blood clots is very rare.
Many countries have been relying on the AstraZeneca vaccine to get them out of the coronavirus pandemic crisis.
But there have been problems – from supply to side-effects.
Recommended Stories
list of 4 items- list 1 of 4What does the US withdrawal from the WHO mean for global health?
- list 2 of 4US officially withdraws from the World Health Organization
- list 3 of 4‘Chaotic’ culture in UK government led to more COVID deaths, inquiry finds
- list 4 of 4Is the world ready for another pandemic?
Now, European regulators say the vaccine can, in rare cases, cause blood clots.
The United Kingdom is to offer alternative jabs to young people, who appear to be more at risk.
But both the UK and the European Union say they remain confident in the AstraZeneca vaccine’s effectiveness and safety.
There have been fewer than 80 cases reported in the UK despite more than 20 million doses being given out.
Should people be worried?
Presenter: Hashem Ahelbarra
Guests:
Chris Smith – Consultant virologist at Cambridge University and podcast host of The Naked Scientists
Oksana Pyzik – Lead on the outbreak of infectious diseases for University College London’s global citizenship programme
Jeffrey Lazarus – Head of the Health Systems Research Group at Barcelona Institute for Global Health